tiprankstipranks
Trending News
More News >
Luen Wong Group Holdings Ltd. (HK:8217)
:8217
Hong Kong Market

Luen Wong Group Holdings Ltd. (8217) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8217

Luen Wong Group Holdings Ltd.

(8217)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
HK$0.37
▼(-1.58% Downside)
The score is held back primarily by weak financial performance (shrinking revenue, ongoing losses, and negative 2025 operating/free cash flow). Offsetting this, technicals show an upward price trend with positive MACD, and valuation appears low on P/E, though fundamentals limit how much credit the low multiple deserves.
Positive Factors
Improvement in Net Losses
The reduction in net losses suggests potential operational improvements and cost management, which could lead to future profitability if sustained.
Moderate Leverage
Moderate leverage indicates a manageable debt level, providing some financial flexibility and reducing immediate solvency risk.
Occasional Strong Cash Flow
The ability to generate strong cash flow in certain years highlights potential for cash generation, which is crucial for funding operations and investments.
Negative Factors
Revenue Contraction
Significant revenue decline indicates a shrinking market presence and challenges in maintaining customer base, impacting long-term growth prospects.
Negative Cash Flow
Negative cash flow raises concerns about liquidity and the ability to fund operations without external financing, threatening financial stability.
Equity Decline
The decline in equity reflects cumulative losses, reducing the company's financial resilience and ability to absorb future shocks.

Luen Wong Group Holdings Ltd. (8217) vs. iShares MSCI Hong Kong ETF (EWH)

Luen Wong Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionJu Fu Tang Biotech Holdings Co., Ltd, an investment holding company, provides civil engineering, decoration, and renovation works in Hong Kong. The company offers road and drainage works, which includes construction and improvement of local road and carriageway junction improvement, as well as associated footpaths, planting areas, drains, sewers, water mains, and utilities diversion services. It also provides structural works, including construction of reinforced concrete structures for bridges and retaining walls; and site formation works, such as excavation and filling works for forming a new site or later development. The company was formerly known as WMHW Holdings Limited and changed its name to Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Ju Fu Tang Biotech Holdings Co., Ltd was incorporated in 2015 and is headquartered in Causeway Bay, Hong Kong.
How the Company Makes MoneyLuen Wong Group Holdings Ltd. generates revenue through contracts for civil engineering services. The company's primary income comes from executing infrastructure projects such as roadworks, drainage systems, and site formations. They secure contracts through competitive bidding processes, often collaborating with governmental bodies or private developers. Key revenue streams include service fees for project management, construction execution, and maintenance services. Strategic partnerships with other construction and engineering firms can enhance their project portfolio, thus influencing their income positively.

Luen Wong Group Holdings Ltd. Financial Statement Overview

Summary
Luen Wong Group Holdings Ltd. faces significant financial challenges, with declining revenues, persistent losses, and operational inefficiencies. The balance sheet shows high leverage and declining equity, raising concerns about financial stability. Cash flow volatility and reliance on financing indicate potential liquidity risks. Overall, the company needs significant improvement in its operational and financial strategies to enhance its financial health.
Income Statement
Luen Wong Group Holdings Ltd. has experienced significant revenue declines from 2020 to 2024, with a sharp drop of approximately 66% from 2023 to 2024. The company has consistently reported net losses over the years, with a negative net profit margin and gross profit margin in the latest period. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies and challenges in cost management.
Balance Sheet
The balance sheet shows a stable debt level but declining stockholders' equity, resulting in a high debt-to-equity ratio. The equity ratio has decreased, reflecting reduced financial stability. The return on equity is negative due to consistent net losses. While cash reserves are relatively stable, the overall financial leverage is high, suggesting potential risks in meeting long-term financial obligations.
Cash Flow
Cash flows have been volatile, with a significant drop in operating cash flow from 2023 to 2024. The company has managed to generate positive free cash flow in the latest year, but the operating cash flow to net income ratio is low due to ongoing losses. The free cash flow to net income ratio indicates reliance on external financing to maintain cash reserves.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue41.30M36.20M35.14M104.60M92.75M168.30M
Gross Profit52.00K982.00K1.88M-2.88M1.04M-2.28M
EBITDA-6.87M-5.10M-16.63M-9.13M-19.14M-12.94M
Net Income-6.50M-5.90M-17.43M-9.96M-20.15M-13.13M
Balance Sheet
Total Assets80.36M80.36M81.55M105.51M144.35M163.21M
Cash, Cash Equivalents and Short-Term Investments30.17M30.17M26.71M44.22M44.70M47.70M
Total Debt12.00M12.00M12.00M12.00M12.15M12.41M
Total Liabilities53.15M53.15M48.44M54.96M83.83M138.44M
Stockholders Equity27.22M27.22M33.12M50.55M60.51M24.76M
Cash Flow
Free Cash Flow-7.27M-7.27M3.72M32.23M-19.52M28.54M
Operating Cash Flow-7.27M-7.27M3.72M32.23M-19.52M28.54M
Investing Cash Flow0.000.000.00806.00K90.00K4.39M
Financing Cash Flow5.38M5.38M-7.87M-33.09M12.05M-21.18M

Luen Wong Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.38
Price Trends
50DMA
0.31
Positive
100DMA
0.29
Positive
200DMA
0.27
Positive
Market Momentum
MACD
0.02
Positive
RSI
69.85
Neutral
STOCH
88.10
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8217, the sentiment is Positive. The current price of 0.38 is above the 20-day moving average (MA) of 0.36, above the 50-day MA of 0.31, and above the 200-day MA of 0.27, indicating a bullish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 69.85 is Neutral, neither overbought nor oversold. The STOCH value of 88.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8217.

Luen Wong Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
HK$142.83M8.255.68%23.93%425.00%
58
Neutral
HK$259.43M4.6411.15%4.56%
56
Neutral
HK$603.83M-36.05-53.25%-45.46%-329.88%
52
Neutral
HK$117.73M5.8252.51%-32.25%
47
Neutral
HK$126.28M-0.91-40.10%-70.99%-2956.76%
45
Neutral
HK$160.00M-0.96-98.05%14.57%13.79%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8217
Luen Wong Group Holdings Ltd.
0.39
0.16
71.05%
HK:1413
Kwong Luen Engineering Holdings Limited
0.39
-0.26
-40.31%
HK:1486
C Cheng Holdings Ltd.
0.60
0.36
150.00%
HK:1751
Kingland Group Holdings Limited
2.08
1.68
420.00%
HK:2227
Solis Holdings Ltd.
0.16
0.07
73.33%
HK:6816
Prosper Construction Holdings Limited
0.20
0.10
100.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025